4 Results for "

histone acetylation sites

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "histone acetylation sites" in MCE Product Catalog:

Cat. No.: HY-W014004
CAS No.: 174664-65-4
Synonyms: CBHA
Target:  

HDAC Apoptosis

Research Areas:  

Others Cancer

m-Carboxycinnamic acid bishydroxamide (CBHA) is a histone deacetylase inhibitor. m-Carboxycinnamic acid bishydroxamide modulates histone acetylation sites, alters DNA methylation and epigenetic status, increases global histone acetylation, alleviates transcription repression, and facilitates chromatin remodelling. m-Carboxycinnamic acid bishydroxamide can be used for the research of cloned embryo development and epigenetic regulation .
loading...
    loading...
Cat. No.: HY-125969
CAS No.: 852935-07-0
Research Areas:  

Infection

Rtt109 inhibitor 1 (Compound 1) is an inhibitor for histone acetyltransferase Rtt109 through a tight binding, uncompetitive system. Rtt109 inhibitor 1 exhibits antifungal activity through acetylation at H3K56 site .
loading...
    loading...
Cat. No.: HY-158308
Target:  

HDAC

Research Areas:  

Cancer

HDAC6-IN-41 (Compound E24) is a selective inhibitor for histone deacetylase 6 (HDAC6), with IC50 of 14 and 422 nM, for HDAC6 and HDAC8, respectively. HDAC6-IN-41 upregulates the acetylation of α-tubulin and histone site SMC3 .
loading...
    loading...
Cat. No.: HY-P11824
Research Areas:  

Cancer

CoA-C2-SGRGK-cCPP is a NatD (NAA40) bisubstrate inhibitor with an IC50 of 78 nM and a Ki of 39 nM. CoA-C2-SGRGK-cCPP competitively targets the peptide substrate binding site and noncompetitively targets the CoA binding site of NatD to block acetyltransferase activity. CoA-C2-SGRGK-cCPP reduces cellular Nα-acetylation on histone H4, modulates EMT marker expression. CoA-C2-SGRGK-cCPP can be used for the research of non-small cell lung cancer .
loading...
    loading...